Almitrine and Raubasine

Vasotherapeutic · Blood oxygenator

Indications

Loss of memory, concentration, vigilance, poor social behaviour, vertigo, tinnitus hypoacusis, impaired coloured vision, visual field and visual acuity due to ischaemia.

Dosage

Adults: 1 tab twice daily at meal times. Children: Not recommended.

Adverse Effects

Weight loss, peripheral neuropathy (withdraw), mild GI disturbances, sleep disturbances, drowsiness, agitation, anxiety, palpitation, dizziness.

Risk Factor (Pregnancy/Lactation)

Pregnancy: Risk cannot be ruled out. Contraindications: Avoid concurrent administration with MAOIs. Precautions: Occurrence of neurological symptoms (prickling, formication, numbness) withdraw.

Interactions

MAOIs.

Advice to Patient

Contact prescriber immediately if there is tingling, prickling, or numbness in the lower limbs. Inform prescriber if you want concomitant use of other medicines containing almitrine.

Pharmacokinetics

ALMITRINE: Absorption: 93% ± 3. Metabolism: Hepatic. Half-life elimination: 20-30 days. Excretion: Renal.

Compiled by Healify Pharmacy from published drug references. How we compile it →

Always consult a pharmacist or doctor.